| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/08/2011 | CA2273825C Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 02/08/2011 | CA2260818C High fidelity detection of nucleic acid differences by ligase detection reaction |
| 02/08/2011 | CA2260363C Polynucleotide and its use for modulating a defence response in plants |
| 02/08/2011 | CA2220830C Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 02/08/2011 | CA2210467C Osteoprotegerin |
| 02/08/2011 | CA2184059C Human trk receptors and neurotrophic factor inhibitors |
| 02/08/2011 | CA2164226C Methods for selectively stimulating proliferation of t cells |
| 02/03/2011 | WO2011014885A1 Thermostable type-a dna polymerase mutants with increased polymerization rate and resistance to inhibitors |
| 02/03/2011 | WO2011014866A1 Materials and methods for diagnosing and treating shellfish allergy |
| 02/03/2011 | WO2011014824A1 Use of collagen type vii for maintaining and re-inducing osteogenic abilities of mesenchymal stem cells |
| 02/03/2011 | WO2011014749A1 Axmi-192 family of pesticidal genes and methods for their use |
| 02/03/2011 | WO2011014693A2 Bacteriophages expressing amyloid peptides and uses thereof |
| 02/03/2011 | WO2011014671A1 Polypeptides that bind tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods |
| 02/03/2011 | WO2011014645A1 Influenza viruses and uses thereof |
| 02/03/2011 | WO2011014605A1 Functionalized cell binding peptides and cell culture articles |
| 02/03/2011 | WO2011014504A1 Recombinant influenza virus vectors and uses thereof |
| 02/03/2011 | WO2011014458A1 Polypeptides having phytase activity and polynucleotides encoding same |
| 02/03/2011 | WO2011014457A1 Combination treatments |
| 02/03/2011 | WO2011013792A1 Kidney imaging agent comprising genetically modified gelatin |
| 02/03/2011 | WO2011013791A1 Kidney-targeting drug delivery agent comprising genetically modified gelatin |
| 02/03/2011 | WO2011013753A1 Marker and reagent for detection of human il-17-producing helper t cells, and method for detection of human il-17-producing helper t cells |
| 02/03/2011 | WO2011013728A1 Motilin-like peptide compound having transmucosal absorbability imparted thereto |
| 02/03/2011 | WO2011013470A1 Autoantibody production inhibitor |
| 02/03/2011 | WO2011013358A1 Anti-tumor agent |
| 02/03/2011 | WO2011013131A1 Polynucleotides and constructs encoding sflt1-14 and method for efficient propagation and expression thereof |
| 02/03/2011 | WO2011013034A1 Antigenic tau peptides and uses thereof |
| 02/03/2011 | WO2011012999A1 Reverse genetics systems |
| 02/03/2011 | WO2011012831A1 Method for purifying active gla-domain coagulation proteins |
| 02/03/2011 | WO2011012830A1 Method for purifying gla-domain coagulation proteins |
| 02/03/2011 | WO2011012718A1 Prodrugs comprising an insulin linker conjugate |
| 02/03/2011 | WO2011012585A1 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity |
| 02/03/2011 | WO2011012254A1 Pichia pastoris as a host for the production of the ribosome-inactivating protein (rip) saporin and saporin fusion chimaeras |
| 02/03/2011 | WO2011012098A1 Method for detecting and identifying a variant c. difficile strain in a sample |
| 02/03/2011 | WO2011012080A1 Derivative of glp-1 analogue or its pharmaceutical salts and their use |
| 02/03/2011 | WO2011011976A1 Homing peptide for tumor vasculature |
| 02/03/2011 | WO2011011841A1 Human blood coagulation factor ix recombinant protein, composition, use of a factor ix recombinant protein, use of a composition, method of obtaining human blood coagulation factor ix recombinant protein and use of the factor ix recombinant protein |
| 02/03/2011 | WO2010139820A8 Method and kit for recognition of microcystin-producing and non-microcystin-producing strains of microcystis aeruginosa (cyanobacteria) |
| 02/03/2011 | WO2010131960A3 New fungal elicitor protein and its use as resistance marker |
| 02/03/2011 | WO2010107639A3 Isolation and characterization of novel green fluorescent proteins from copepods |
| 02/03/2011 | WO2010093954A3 Control of plant stress tolerance, water use efficiency and gene expression using novel aba receptor proteins and synthetic agonists |
| 02/03/2011 | WO2010091294A9 New targeted antimicrobial moieties |
| 02/03/2011 | WO2007035872A3 Tdf-related compounds and analogs thereof |
| 02/03/2011 | US20110030108 Mammalian-type glycosylation in plants |
| 02/03/2011 | US20110030106 Brassica plant comprising a mutant indehiscent allele |
| 02/03/2011 | US20110030096 AXMI-192 Family of Pesticidal Genes and Methods for Their Use |
| 02/03/2011 | US20110030094 Nucleic Acid Sequences Encoding Proteins Associated with Abiotic Stress Response and Plant Cells with Increased Tolerance to Environmental Stress |
| 02/03/2011 | US20110030090 Disease resistance genes |
| 02/03/2011 | US20110030077 METHODS OF MODULATING THE ORGANIC SOLUTE AND STEROID TRANSPORTER (OSTalpha-OSTbeta) ACTIVITY AND TREATING ASSOCIATED CONDITIONS |
| 02/03/2011 | US20110030076 Methods and compositions for targeted cleavage and recombination |
| 02/03/2011 | US20110028700 Mutant proteins and methods for producing them |
| 02/03/2011 | US20110028699 Agent for Treating Skin Aging and Scars |
| 02/03/2011 | US20110028698 Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties |
| 02/03/2011 | US20110028693 Blood coagulation protein conjugates |
| 02/03/2011 | US20110028692 Multisignaling oligomeric or polymeric compositions comprising labeled moieties and binding partners |
| 02/03/2011 | US20110028691 Recombinant toxin fragments |
| 02/03/2011 | US20110028690 Novel bag proteins and nucleic acid molecules encoding them |
| 02/03/2011 | US20110028689 Nucleic acids that encode sodium channel |
| 02/03/2011 | US20110028688 Crystal structure of ox40l and ox40l complexed with ox40 receptor |
| 02/03/2011 | US20110028687 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 02/03/2011 | US20110028686 Protein binding miniature proteins |
| 02/03/2011 | US20110028685 Analyte Determination Utilizing Mass Tagging Reagents Comprising A Non-Encoded Detectable Label |
| 02/03/2011 | US20110028633 Dispersing Agents in Nanocomposites |
| 02/03/2011 | US20110028533 Novel fer -like protein, pharmaceutical compositions containing it and method for its use |
| 02/03/2011 | US20110028409 Detection of anti-ribosomal p protein antibodies by means of synthetic peptides |
| 02/03/2011 | US20110028403 HSP70-Based Treatment for Autoimmune Diseases and Cancer |
| 02/03/2011 | US20110028402 Substance p-saporin (sp-sap) conjugates and methods of use |
| 02/03/2011 | US20110028399 Citrullinated cytokines |
| 02/03/2011 | US20110028397 Use of Urokinase Type Plasminogen Activator Inhibitors for the Treatment of Corneal Disorders |
| 02/03/2011 | US20110028388 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
| 02/03/2011 | US20110028387 METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF |
| 02/03/2011 | US20110028386 Antimicrobial Peptides |
| 02/03/2011 | US20110028384 Rap variants for drug delivery |
| 02/03/2011 | US20110028383 Activated Forms Of Notch And Methods Based Thereon |
| 02/03/2011 | US20110027912 Purified serum albumin, and immunological measurement method |
| 02/03/2011 | US20110027910 Screening |
| 02/03/2011 | US20110027909 Chimera Compositions and Methods of Use |
| 02/03/2011 | US20110027907 Ssl7 mutants and uses therefor |
| 02/03/2011 | US20110027890 Material for cell culture |
| 02/03/2011 | US20110027867 Methods and compositions for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs |
| 02/03/2011 | US20110027861 Desiccated Biologics And Methods Of Preparing The Same |
| 02/03/2011 | US20110027855 Maize Cellulose Synthases and Uses Thereof |
| 02/03/2011 | US20110027830 Use of an aspartic protease (ns24) signal sequence for heterologous protein expression |
| 02/03/2011 | US20110027829 Methods and Compositions |
| 02/03/2011 | US20110027810 Chimeric recombinant antigens of toxoplasma gondii |
| 02/03/2011 | US20110027807 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/03/2011 | US20110027805 Acpl-related assays |
| 02/03/2011 | US20110027800 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings |
| 02/03/2011 | US20110027414 Mutant ilv5 gene and use thereof |
| 02/03/2011 | US20110027347 Polymersomes and methods of making and using thereof |
| 02/03/2011 | US20110027337 Protease inhibitor |
| 02/03/2011 | US20110027318 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis |
| 02/03/2011 | US20110027306 TC-83-Derived Alphavirus Vectors, Particles and Methods |
| 02/03/2011 | US20110027304 Yersinia pestis antigens, vaccine compositions and related methods |
| 02/03/2011 | US20110027303 Partial peptide of survivin presented on mhc class ii molecule and use therof |
| 02/03/2011 | US20110027299 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/03/2011 | US20110027282 Interferon antagonists, antibodies thereto and associated methods of use |
| 02/03/2011 | US20110027279 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 02/03/2011 | US20110027267 Fusion Proteins of Mannose Binding Lectins for Treatment of Disease |
| 02/03/2011 | US20110027263 Soluble interleukin-20 receptor |
| 02/03/2011 | US20110027260 Bcl-g polypeptides, encoding nucleic acids and methods of use |